ImmunityBio, Inc. — Director's Dealing 2018

May 24, 2018

SEC Form 4/A — Form 4/A

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2018-05-21

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-21	Common Stock	S	5557	$3.998	Disposed	418449	Indirect
2018-05-22	Common Stock	S	8546	$3.9119	Disposed	409903	Indirect

Footnotes

F1: Represents the weighted average share price of an aggregate total of 5,557
shares sold in the price range of $3.97 to $4.01 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: This amendment is being filed to correct the weighted average share price for shares sold May 21, 2018 and May 22, 2018 as reported in the Form 4 filed on May 23, 2018.

F3: Represents the weighted average share price of an aggregate total of 8,546 shares sold in the price range of $3.91 to $3.925 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.